AACR PATIENT ADVOCATE FORUM: AI in Cancer Research, Care, and Survivorship

Artificial Intelligence in Cancer Research, Care, and Survivorship: Current Status and What’s Next

Tuesday, March 24, 2026, 3:30-5 pm ET

Artificial intelligence (AI) is becoming an increasingly important tool in cancer research, helping scientists analyze complex data, identify patterns, and accelerate discoveries that may ultimately improve patient care. This AACR Patient Advocate Forum will focus on how AI is being used today in cancer research and clinical care and how these advances are expected to influence cancer prevention, early detection, treatment, and survivorship in the years ahead.

The discussion will explore where AI-driven research is showing the most promise, how and when these scientific advances may translate into clinical care, and what this means for patients and survivors. Speakers will also address challenges that remain, including data quality, bias, transparency, access, and why patient advocate perspectives are essential to guiding responsible research and implementation. Join us to learn about the science behind AI in cancer research and feel more prepared to engage in conversations about how these innovations can, and should, benefit patients with cancer.

MODERATOR

Anna D. Barker, PhD, FAACR, Ellison Medical Institute, Los Angeles, CA

SPEAKERS

George W. Sledge, Jr., MD, Caris Life Sciences, Palo Alto, CA

Carlo C. Maley, PhD, Arizona State University, Tempe, AZ

Saranne Rothberg, Comedy Cures, Tenafly, NJ

AACR Patient Advocate Forums

The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Virtual Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and healthcare communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public.